These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 23959856)
1. Tumor cells upregulate normoxic HIF-1α in response to doxorubicin. Cao Y; Eble JM; Moon E; Yuan H; Weitzel DH; Landon CD; Nien CY; Hanna G; Rich JN; Provenzale JM; Dewhirst MW Cancer Res; 2013 Oct; 73(20):6230-42. PubMed ID: 23959856 [TBL] [Abstract][Full Text] [Related]
2. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766 [TBL] [Abstract][Full Text] [Related]
3. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ; Bellamy WT; Briehl MM; Powis G Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766 [TBL] [Abstract][Full Text] [Related]
4. Regulation of HIF-1alpha stability through S-nitrosylation. Li F; Sonveaux P; Rabbani ZN; Liu S; Yan B; Huang Q; Vujaskovic Z; Dewhirst MW; Li CY Mol Cell; 2007 Apr; 26(1):63-74. PubMed ID: 17434127 [TBL] [Abstract][Full Text] [Related]
5. Anterior gradient 2 is a binding stabilizer of hypoxia inducible factor-1α that enhances CoCl2 -induced doxorubicin resistance in breast cancer cells. Li Z; Zhu Q; Hu L; Chen H; Wu Z; Li D Cancer Sci; 2015 Aug; 106(8):1041-9. PubMed ID: 26079208 [TBL] [Abstract][Full Text] [Related]
6. Maslinic acid induces mitochondrial apoptosis and suppresses HIF-1α expression in A549 lung cancer cells under normoxic and hypoxic conditions. Hsia TC; Liu WH; Qiu WW; Luo J; Yin MC Molecules; 2014 Nov; 19(12):19892-906. PubMed ID: 25460312 [TBL] [Abstract][Full Text] [Related]
7. HIF-1α forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells. Zhu B; Pan S; Liu J; Wang S; Ni Y; Xiao L; Wei Q; Peng Y; Ding Z; Zhao W Cell Biol Int; 2020 Feb; 44(2):456-466. PubMed ID: 31617641 [TBL] [Abstract][Full Text] [Related]
8. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Carroll VA; Ashcroft M Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol reduces the hypoxia-induced resistance to doxorubicin in breast cancer cells. Mitani T; Ito Y; Harada N; Nakano Y; Inui H; Ashida H; Yamaji R J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):122-8. PubMed ID: 24975222 [TBL] [Abstract][Full Text] [Related]
12. The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia. Fourie C; du Plessis M; Mills J; Engelbrecht AM Exp Cell Res; 2022 Oct; 419(2):113334. PubMed ID: 36044939 [TBL] [Abstract][Full Text] [Related]
13. The role of nitric oxide (NO) in stability regulation of hypoxia inducible factor-1alpha (HIF-1alpha). Brüne B; Zhou J Curr Med Chem; 2003 May; 10(10):845-55. PubMed ID: 12678687 [TBL] [Abstract][Full Text] [Related]
14. Accumulation of HIF-1alpha under the influence of nitric oxide. Sandau KB; Fandrey J; Brüne B Blood; 2001 Feb; 97(4):1009-15. PubMed ID: 11159530 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988 [TBL] [Abstract][Full Text] [Related]
16. Potential role of the methylation of VEGF gene promoter in response to hypoxia in oxygen-induced retinopathy: beneficial effect of the absence of AQP4. Pisani F; Cammalleri M; Dal Monte M; Locri F; Mola MG; Nicchia GP; Frigeri A; Bagnoli P; Svelto M J Cell Mol Med; 2018 Jan; 22(1):613-627. PubMed ID: 28940930 [TBL] [Abstract][Full Text] [Related]
17. Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity. Fang Y; Sullivan R; Graham CH Exp Cell Res; 2007 Mar; 313(5):867-77. PubMed ID: 17289019 [TBL] [Abstract][Full Text] [Related]
18. Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. Peng XH; Karna P; Cao Z; Jiang BH; Zhou M; Yang L J Biol Chem; 2006 Sep; 281(36):25903-14. PubMed ID: 16847054 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer. Zhu H; Zhang S J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944 [TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide and interferon-γ team up to activate HIF-1α via STAT1 in normoxia and exhibit sex differences in human aortic valve interstitial cells. Parra-Izquierdo I; Castaños-Mollor I; López J; Gómez C; San Román JA; Sánchez Crespo M; García-Rodríguez C Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2168-2179. PubMed ID: 31034990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]